1. Home
  2. LARK vs TLSA Comparison

LARK vs TLSA Comparison

Compare LARK & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

N/A

Current Price

$25.64

Market Cap

167.8M

Sector

Finance

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.52

Market Cap

182.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LARK
TLSA
Founded
1885
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.8M
182.7M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
LARK
TLSA
Price
$25.64
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.3K
372.2K
Earning Date
02-03-2026
05-06-2025
Dividend Yield
3.22%
N/A
EPS Growth
38.73
N/A
EPS
2.84
N/A
Revenue
$64,367,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.80
N/A
Revenue Growth
12.95
N/A
52 Week Low
$20.99
$0.63
52 Week High
$29.56
$2.60

Technical Indicators

Market Signals
Indicator
LARK
TLSA
Relative Strength Index (RSI) 24.40 44.96
Support Level $24.85 $1.44
Resistance Level $26.03 $1.61
Average True Range (ATR) 0.70 0.13
MACD -0.40 0.01
Stochastic Oscillator 4.90 61.89

Price Performance

Historical Comparison
LARK
TLSA

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: